Key Findings:  This survey of medical cannabis users with rheumatoid arthritis was twice that of the general population Cannabis use was also associated with more severe disease, and pain, and also reported prior recreational use. They also concluded several barriers exist in authorization for use by rheumatologists including a lack of research, knowledge, and standardization.
Type of Study:  Meta-analysis
Study Sample Size:  799
Study Result:  Negative
Research Location(s):  Canada
Year of Pub:  2022
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Unspecified
Citation:  Rampakakis E, et al. Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative. Clin Exp Rheumatol. 2023; 41:118-125. doi: 10.55563/clinexprheumatol/b85xu5
Authors:  Rampakakis E, Thorne C, Cesta A, Movahedi M, Li X, Mously C, Ahluwalia V, Brophy J, Ciaschini P, Keystone E, Lau A, Major G, Pavlova V, Pope JE, Bombardier C